市场调查报告书
商品编码
1279009
维生素 K 市场:按类型、应用、给药途径、分销渠道和预测,2023-2032 年Vitamin K Market - By Type, By Application, By Route of Administration, By Distribution Channel & forecast, 2023 - 2032 |
在对维生素补充剂的高需求的推动下,预计从 2023 年到 2032 年,全球维生素 K 市场将以温和的速度增长。
人们对维生素补充剂益处的认识不断提高预计将促进该行业的发展。 大量临床数据支持维生素对一般健康的重要性及其对人体(尤其是骨骼)的益处,从而提高了人们对克服维生素 K 缺乏症和相关疾病的认识和需求。 因此,注射剂、口服补充剂和膳食补充剂等维生素 K 类产品的销售额显着增加。
除此之外,药物输送系统的持续技术创新将进一步加速市场的增长。 生物製品行业的积极前景和药物自我管理的引入将在 2023-2032 年刺激对维生素 K 的需求。
维生素 K 市场按应用、给药途径、分销渠道和地区划分。
到 2022 年,维生素 K 缺乏性出血 (VKDB) 应用领域的维生素 K 市场价值将超过 1.9 亿美元,到 2032 年将具有巨大的吸引力。 维生素 K 缺乏症 在婴儿中,维生素 K 缺乏症会导致出血。 根据疾病控制和预防中心的数据,早期和经典 VKDB 更为常见,每 60 至 250 名新生儿中就有 1 人受到影响,而晚期 VKDB 则较为罕见,每 14,000 至 1,000 名新生儿中就有 1 人受到影响。每 25,000 名儿童中就有 1 人受到影响。 肠道、大脑和身体其他部位的出血在患有 VKDB 的婴儿中很常见,这被认为是导致对该产品需求增加的原因。
从给药途径来看,口服维生素 K 市场将在 2032 年增长,原因是患者的接受度和舒适度、非侵入性、可负担性以及大规模生产的便利性。预计将有很高的采用率率直到 随着慢性病发病率的增加,口服给药的使用率增加,这支持了该细分市场的扩张。
根据分销渠道,线下细分市场的维生素 K 市场份额预计将在 2023 年至 2032 年间呈指数级增长。 分销商、批发商和零售商等线下渠道用于将产品分销给目标客户。 线下分销渠道包括大卖场、超市、专卖店和药店。 预计为客户提供更广泛的各种产品选择将推动该细分市场的增长。
按地区划分,亚太地区的维生素 K 市场预计将以超过 10.5% 的复合年增长率增长。 2023 年至 2032 年的复合年增长率为 5%。 不断上升的生育率和不断增长的老年人口增加了维生素补充剂的流行和可用性,推动了市场扩张。 此外,亚太国家见证了全球竞争对手的存在,以及政府在医疗保健研发方面的支出不断增加,预计这将推动该地区的市场增长。
Global Vitamin K Market is set to expand at a decent growth rate from 2023 to 2032, driven by the high demand for vitamin supplements.
Rising awareness of the advantages of vitamin supplements is projected to contribute to the industry growth. A substantial amount of clinical data supports the significance of vitamins in general health and their benefits to the human body, particularly the bones, leading to increased awareness and demand for vitamin K to overcome deficiencies and related disorders. As a result, the sales of vitamin K-based products such as injections, oral supplements, and dietary supplements has grown substantially.
This apart, the consistent technological innovations in the medication delivery system will further accelerate market growth. The positive outlook of the biologics sector and the introduction of medication self-administration will stimulate the demand for vitamin K over 2023-2032.
The vitamin K market is segmented as per application, route of administration, distribution channel, and region.
The vitamin K market from the Vitamin K deficiency bleeding (VKDB) application segment was valued at over USD 190 million in 2022 and is poised to gain significant traction through 2032. A lack of vitamin K In babies, a deficiency of vitamin K causes bleeding. As per the Centers for Disease Control and Prevention, early and classical VKDB is more common, affecting 1 in 60 to 1 in 250 neonates, but late VKDB is uncommon, affecting 1 in 14,000 to 1 in 25,000 children. Bleeding inside the body, such as the intestines or brain, is prevalent in babies with VKDB, which may contribute to the rising product demand.
By route of administration, the vitamin K market from the oral segment is projected to witness a high adoption rate through 2032 due to its several benefits, such as patient acceptance and comfort, non-invasiveness, affordability, and convenience of manufacturing on a large scale. As the frequency of chronic illnesses rises, the usage of oral administration will increase, thereby supporting segment expansion.
Based on the distribution channel, the vitamin K market share from the offline segment is estimated to grow exponentially between 2023 and 2032. Offline channels, such as distributors, wholesalers, and retailers, are used to distribute the product to the target customers. Offline distribution channels include hypermarkets, supermarkets, specialized stores, and pharmacy stores. The widespread availability of a range of product options to customers is likely to facilitate segment growth.
Regionally, the Asia Pacific vitamin K market is anticipated to grow at more than 10. 5% CAGR over 2023-2032. The increasing birth rate and rise in the geriatric population have increased the adoption rate and availability of vitamin supplements, thereby driving market expansion. Furthermore, the strong presence of global competitors throughout APAC nations, in line with rising government spending for healthcare R&D, will promote regional market growth.